Edge Therapeutics, Inc. (Nasdaq: EDGE) to Ring The Nasdaq Stock Market Closing Bell
August 19 2016 - 10:00AM
What: Edge Therapeutics, Inc.
(Nasdaq:EDGE), a clinical-stage biotechnology company developing
novel hospital-based therapies for the management of acute,
life-threatening conditions, will visit the Nasdaq MarketSite in
Times Square.
In honor of the occasion, Brian Leuthner,
President and CEO, and Dr. R. Loch
Macdonald, Chief Scientific Officer, will ring the Closing
Bell.
Where: Nasdaq MarketSite – 4 Times Square
– 43rd & Broadway – Broadcast Studio
When: Monday, August 22, 2016 – 3:45 p.m.
to 4:00 p.m. ET
Edge Therapeutics, Inc. Contact: Gregory
Gin (800) 208-3343 ir@edgetherapeutics.com
Nasdaq MarketSite: Emily Pan (646)
441-5120 emily.pan@nasdaq.com
Feed Information: Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media: For multimedia features such
as exclusive content, photo postings, status updates and video of
bell ceremonies, please visit our Facebook
page: http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page: http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page: http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page: http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page: http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Edge Therapeutics, Inc. Edge
Therapeutics, Inc. (Edge) is a clinical-stage biotechnology company
that discovers, develops and seeks to commercialize novel,
hospital-based therapies capable of transforming treatment
paradigms for the management of acute, life-threatening
neurological conditions. EG-1962, Edge’s lead product candidate,
has the potential to fundamentally improve patient outcomes and
transform the management of aneurysmal subarachnoid hemorrhage, or
aSAH, which is bleeding around the brain due to a ruptured brain
aneurysm. For additional information about Edge, please visit
www.edgetherapeutics.com.
About Nasdaq Nasdaq (Nasdaq:NDAQ) is a
leading provider of trading, clearing, exchange technology,
listing, information and public company services across six
continents. Through its diverse portfolio of solutions, Nasdaq
enables customers to plan, optimize and execute their business
vision with confidence, using proven technologies that provide
transparency and insight for navigating today's global capital
markets. As the creator of the world's first electronic stock
market, its technology powers more than 70 marketplaces in 50
countries, and 1 in 10 of the world's securities transactions.
Nasdaq is home to more than 3,700 listed companies with a market
value of approximately $9.3 trillion and nearly 18,000 corporate
clients. To learn more, visit: nasdaq.com/ambition or
business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2024 to May 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From May 2023 to May 2024